Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/10987
Title: The ceramide transporter and the Goodpasture antigen binding protein: one protein - one function?
Authors: Mencarelli, Chiara
Losen, Mario
Hammels, Caroline
DE VRY, Jochen 
Hesselink, Matthijs K. C.
STEINBUSCH, Harry 
Martinez-Martinez, Pilar
DE BAETS, Marc 
Issue Date: 2010
Publisher: WILEY-BLACKWELL PUBLISHING, INC
Source: JOURNAL OF NEUROCHEMISTRY, 113 (6). p. 1369-1386
Abstract: P>The Goodpasture antigen-binding protein (GPBP) and its splice variant the ceramide transporter (CERT) are multifunctional proteins that have been found to play important roles in brain development and biology. However, the function of GPBP and CERT is controversial because of their involvement in two apparently unrelated research fields: GPBP was initially isolated as a protein associated with collagen IV in patients with the autoimmune disease Goodpasture syndrome. Subsequently, a splice variant lacking a serine-rich domain of 26 amino acids (GPBP Delta 26) was found to mediate the cytosolic transport of ceramide and was therefore (re)named CERT. The two splice forms likely carry out different functions in specific sub-cellular localizations. Selective GPBP knockdown induces extensive apoptosis and tissue loss in the brain of zebrafish. GPBP/GPBP Delta 26 knock-out mice die as a result of structural and functional defects in endoplasmic reticulum and mitochondria. Because both mitochondria and ceramide play an important role in many biological events that regulate neuronal differentiation, cellular senescence, proliferation and cell death, we propose that GPBP and CERT are pivotal in neurodegenerative processes. In this review, we discuss the current state of knowledge on GPBP and CERT, including the molecular and biochemical characterization of GPBP in the field of autoimmunity as well as the fundamental research on CERT in ceramide transport, biosynthesis, localization, metabolism and cell homeostasis.
Notes: [Mencarelli, Chiara; Losen, Mario; Hammels, Caroline; De Vry, Jochen; Steinbusch, Harry W. M.; De Baets, Marc H.; Martinez-Martinez, Pilar] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Fac Hlth Med & Life Sci, NL-6200 MD Maastricht, Netherlands. [Hesselink, Matthijs K. C.] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, Dept Human Movement Sci, NL-6200 MD Maastricht, Netherlands. [De Baets, Marc H.] Hasselt Univ, Biomed Res Inst BIOMED, Neuroimmunol Grp, Diepenbeek, Belgium. p.martinez@maastrichtuniversity.nl
Keywords: autoimmunity; ceramide; GPBP; CERT; neurodegenerative diseases;autoimmunity; ceramide; GPBP; CERT; neurodegenerative diseases
Document URI: http://hdl.handle.net/1942/10987
ISSN: 0022-3042
e-ISSN: 1471-4159
DOI: 10.1111/j.1471-4159.2010.06673.x
ISI #: 000278309900002
Category: A1
Type: Journal Contribution
Validations: ecoom 2011
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
de baets 1.pdf
  Restricted Access
Published version798.38 kBAdobe PDFView/Open    Request a copy
Show full item record

SCOPUSTM   
Citations

27
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

31
checked on Apr 14, 2024

Page view(s)

120
checked on Sep 7, 2022

Download(s)

132
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.